Vittoria Biotherapeutics develops gene-edited cell therapies.  they provide next-generation, paradigm-shifting T-cell therapeutics that address unmet medical needs. Senza5 Technology from viTToria improves the efficacy, safety, and utility of cell-based treatments in preclinical settings.

Biotechnology

Health Data

Test & Measurement

viTToria biotherapeutics

The Scientific Advisory Team at viTToria Biotherapeutics consists of esteemed experts who provide strategic guidance on the development and application of gene-edited cell therapies, focusing on enhancing the efficacy, safety, and utility of T-cell therapeutics. Their insights help drive the innovation and preclinical success of Senza5 Technology, ensuring the company's solutions address critical unmet medical needs.

Scientific Advisory Team

The Leadership Team at Vittoria Biotherapeutics drives the strategic vision and operational excellence necessary to develop and deliver groundbreaking gene-edited cell therapies. Comprising experienced founders and executives, this team oversees clinical advancements, regulatory compliance, and partnerships to ensure the successful implementation of Senza5 Technology in addressing unmet medical needs.

��

People (8)

Jobs (0)

Other teams

Leadership Team

��������

People (8)

Jobs (0)

Other teams

Leadership Team

��